Regulatory T Cells in Health and Disease
MedComm · 2026-11 · 7 (11)
DOI: 10.1002/mco2.71107 ↗Abstract
ABSTRACT Regulatory T cells (Tregs) are central guardians of immune tolerance and tissue homeostasis. Initially defined as suppressors of excessive immune responses, Tregs are now recognized as adaptable cells that integrate antigenic, cytokine, metabolic, and tissue‐derived signals to coordinate immune regulation, inflammation resolution, and tissue repair. However, these dimensions are often considered separately, and their interrelationships across physiological and pathological contexts remain insufficiently integrated. Here, we summarize the developmental origin, lineage stability, plasticity, and tissue adaptation of Tregs, and examine how these features shape their context‐dependent functions. In lymphoid organs, Tregs maintain systemic tolerance by limiting antigen‐presenting cell activation, restraining IL‐2 availability, and setting the threshold for T‐ and B‐cell responses, whereas in non‐lymphoid tissues, they acquire organ‐specific transcriptional, metabolic, and migratory programs that support barrier integrity, metabolic fitness, and regenerative repair. Chronic inflammation, persistent antigenic stimulation, oxidative stress, and metabolic disturbance can in turn disrupt these programs, promoting functional reprogramming or lineage instability, while excessive Treg‐mediated suppression may favor pathogen persistence and tumor immune escape. We further discuss Treg alterations across major disease settings and emerging Treg‐targeted therapies, providing an integrated framework that links developmental origin, tissue context, and functional state to more precise therapeutic strategies.
EUVIMED